IPIX (Innovation Pharmaceuticals) ROCE %: -168.36% (As of Sep. 2023)

What is Innovation Pharmaceuticals ROCE %?

Innovation Pharmaceuticals IPIX ROCE % is -168.36% as of Sep. 2023.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Innovation Pharmaceuticals's annualized ROCE % for the quarter that ended in Sep. 2023 was -168.36%.

Innovation Pharmaceuticals (OTCPK:IPIX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Innovation Pharmaceuticals ROCE % Related Terms

Innovation Pharmaceuticals ROCE % Historical Data

* Premium members only.

The historical data trend for Innovation Pharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation Pharmaceuticals ROCE % Chart

Innovation Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROCE %

Get a 7-Day Free Trial

0.00

-187.03

-103.90

-77.13

Innovation Pharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial															-115.61	-34.38	-77.16	-94.83	-168.36

Innovation Pharmaceuticals ROCE % Calculation

Innovation Pharmaceuticals's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	-3.111	/	( ( (10.379 - 4.808)	+	(7.517 - 5.021) )	/ 2 )
	=	-3.111	/	( (5.571	+	2.496)	/ 2 )
	=	-3.111	/	4.0335
	=	-77.13 %

Innovation Pharmaceuticals's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	-3.464	/	( ( (7.517 - 5.021)	+	(6.667 - 5.048) )	/ 2 )
	=	-3.464	/	( ( 2.496	+	1.619 )	/ 2 )
	=	-3.464	/	2.0575
	=	-168.36 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -168.36% mean?

Innovation Pharmaceuticals (IPIX) has a ROCE % of -168.36% as of Sep. 2023.

Is Innovation Pharmaceuticals' ROCE % too high?

Innovation Pharmaceuticals' current ROCE % is -168.36%.

How does Innovation Pharmaceuticals' ROCE % compare to AXIM and RNAZ?

Innovation Pharmaceuticals' ROCE % of -168.36% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Biotechnology company?

A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. Innovation Pharmaceuticals's current ROCE % is -168.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Innovation Pharmaceuticals stock overvalued right now?

Innovation Pharmaceuticals (IPIX) has a current ROCE % of -168.36%. The current ROCE % is -168.36%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Innovation Pharmaceuticals (IPIX), the current ROCE % is -168.36% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies AXIM RNAZ APTX CPMV VRAX KPRX NEXI QRON ENDV ENVB OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Address 301 Edgewater Place, Suite 100, Wakefield, MA, USA, 01880

Website http://www.ipharminc.com

Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, and inflammatory disease.